Victory Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Victory Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,181	Closed	-$221K	–	2611
2020 Q3	$221K	Sell	4,181 -128	-3%	-$7.9K	﹤0.01%	2260
2020 Q2	$264K	Sell	4,309 -2,355	-35%	-$136K	﹤0.01%	2218
2020 Q1	$376K	Buy	6,664 +3,554	+114%	+$203K	﹤0.01%	2179
2019 Q4	$177K	Sell	3,110 -1,513	-33%	-$80.2K	﹤0.01%	2339
2019 Q3	$247K	Buy	4,623 +3,173	+219%	+$185K	﹤0.01%	2148
2019 Q2	$87K	Sell	1,450 -2,521	-63%	-$159K	﹤0.01%	1654
2019 Q1	$248K	Buy	+3,971	New	+$263K	﹤0.01%	1519

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Victory Capital Management's BSTC Position: Q4 2020 in Review

Victory Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 4,181 shares — an estimated $221K sold.

Victory Capital Management first reported a position in BSTC in Q1 2019 and held it in 7 quarters. The position peaked at $376K in Q1 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Victory Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Victory Capital Management sold 4,181 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $221K.
Victory Capital Management first reported a position in BioSpecifics Technologies Corp. in Q1 2019 and held it in 7 quarters.
Victory Capital Management's BioSpecifics Technologies Corp. position peaked at $376K in Q1 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Victory Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.